DK1793859T3 - Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18 - Google Patents

Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18

Info

Publication number
DK1793859T3
DK1793859T3 DK05789011T DK05789011T DK1793859T3 DK 1793859 T3 DK1793859 T3 DK 1793859T3 DK 05789011 T DK05789011 T DK 05789011T DK 05789011 T DK05789011 T DK 05789011T DK 1793859 T3 DK1793859 T3 DK 1793859T3
Authority
DK
Denmark
Prior art keywords
human
treatment
oral
administration
intestinal mucositis
Prior art date
Application number
DK05789011T
Other languages
Danish (da)
English (en)
Inventor
Judithann Lee
Kimberly A Dede
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1793859T3 publication Critical patent/DK1793859T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05789011T 2004-08-20 2005-08-18 Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18 DK1793859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60301204P 2004-08-20 2004-08-20
PCT/US2005/029358 WO2006023623A2 (en) 2004-08-20 2005-08-18 Methods of healing wounds by administering human il-18

Publications (1)

Publication Number Publication Date
DK1793859T3 true DK1793859T3 (da) 2009-06-22

Family

ID=35968167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05789011T DK1793859T3 (da) 2004-08-20 2005-08-18 Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18

Country Status (24)

Country Link
US (1) US7595039B2 (pt)
EP (2) EP1793859B1 (pt)
JP (1) JP4912306B2 (pt)
KR (1) KR20070050924A (pt)
CN (1) CN101039696B (pt)
AT (2) ATE526057T1 (pt)
AU (1) AU2005277404A1 (pt)
BR (1) BRPI0514445A (pt)
CA (1) CA2577777A1 (pt)
CY (1) CY1108991T1 (pt)
DE (1) DE602005013542D1 (pt)
DK (1) DK1793859T3 (pt)
ES (2) ES2322605T3 (pt)
HK (1) HK1109054A1 (pt)
IL (1) IL181286A0 (pt)
MX (1) MX2007002134A (pt)
NO (1) NO20071238L (pt)
NZ (1) NZ552837A (pt)
PL (1) PL1793859T3 (pt)
PT (1) PT1793859E (pt)
RU (1) RU2387455C2 (pt)
SI (1) SI1793859T1 (pt)
WO (1) WO2006023623A2 (pt)
ZA (1) ZA200700524B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201305214A (zh) * 2000-02-10 2013-02-01 Abbott Gmbh & Co Kg 與人類間白素-18結合之抗體,及其製法及用途
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
WO2012174056A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
US10858426B2 (en) * 2013-09-05 2020-12-08 Ab2 Bio Sa IL-18 binding protein (IL-18BP) in inflammatory diseases
SG11201706879UA (en) 2015-03-05 2017-09-28 Ab2 Bio Sa Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69519454T2 (de) 1994-07-14 2001-05-03 Hayashibara Biochem Lab Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
US5680795A (en) 1995-07-05 1997-10-28 Norco Inc. Mechanical drive assembly incorporating counter-spring biassed radially-adjustable rollers
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
AU7516601A (en) * 2000-06-02 2001-12-17 Susan B Dillon Methods of treating viral diseases with il-18 and il-18 combinations
CA2412730C (en) * 2000-06-15 2011-08-16 Smithkline Beecham Corporation Method for preparing a physiologically active il-18 polypeptide
EP1405560B1 (en) * 2001-07-12 2011-10-19 Taiho Pharmaceutical Co., Ltd. Il-18 transgenic animal
CA2499014A1 (en) * 2002-09-16 2004-03-25 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREOF
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
EP1793859A4 (en) 2008-02-13
ES2372728T3 (es) 2012-01-25
CN101039696A (zh) 2007-09-19
EP2161032A2 (en) 2010-03-10
JP2008510709A (ja) 2008-04-10
ATE426410T1 (de) 2009-04-15
ZA200700524B (en) 2008-05-28
BRPI0514445A (pt) 2008-06-10
DE602005013542D1 (de) 2009-05-07
IL181286A0 (en) 2007-07-04
US20060039892A1 (en) 2006-02-23
AU2005277404A1 (en) 2006-03-02
PL1793859T3 (pl) 2009-08-31
EP1793859B1 (en) 2009-03-25
WO2006023623A2 (en) 2006-03-02
EP2161032B1 (en) 2011-09-28
JP4912306B2 (ja) 2012-04-11
CA2577777A1 (en) 2006-03-02
US7595039B2 (en) 2009-09-29
RU2387455C2 (ru) 2010-04-27
NZ552837A (en) 2009-09-25
PT1793859E (pt) 2009-06-04
WO2006023623A3 (en) 2006-08-24
SI1793859T1 (sl) 2009-06-30
EP2161032A3 (en) 2010-07-28
CN101039696B (zh) 2011-08-17
ES2322605T3 (es) 2009-06-23
MX2007002134A (es) 2007-09-14
CY1108991T1 (el) 2014-07-02
NO20071238L (no) 2007-05-14
EP1793859A2 (en) 2007-06-13
RU2007110166A (ru) 2008-09-27
ATE526057T1 (de) 2011-10-15
HK1109054A1 (en) 2008-05-30
KR20070050924A (ko) 2007-05-16

Similar Documents

Publication Publication Date Title
BR0211079A (pt) Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DK1163904T3 (da) Sammensætning til forebyggelse af glat muskelsygdom, der omfatter ascorbat, arginin og magnesium
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
PA8607201A1 (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
WO2006137100A3 (en) Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field
ATE480243T1 (de) Zusammensetzung zur verwendung bei diagnose der akuten verletzungen des zentralen nervensystems
DK1793859T3 (da) Behandling af oral og intestinal mucositis ved indgivelse af humant IL-18
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
IL177169A (en) Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
CY1112440T1 (el) Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3
DK1818052T3 (da) Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre
DE502004011874D1 (de) Flupirtine-präparat zur behandlung von neurodegeneetes mellitus
DE50310383D1 (de) Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen
DK1365795T3 (da) Anvendelse af G-CSF som yderligere behandling i rekonstruktionen af bindevæv
Miller et al. Burns to the Feet
WO2004069795A3 (en) Diagnosis and treatment of chronic tissue damage
ITAN20040031A1 (it) Prodotto e metodo per la cura del diabete
ITSA20050018A1 (it) Composizione per la cura di patologie osteo-articolari, muscolari e tendinee